François Herrmann mainly investigates Internal medicine, Immunology, Pathology, Dementia and Molecular biology. His work deals with themes such as Gastroenterology, Endocrinology and Surgery, which intersect with Internal medicine. His work investigates the relationship between Immunology and topics such as Toxicity that intersect with problems in Reticulocyte, Hematopoietic growth factor and Interleukin 3.
François Herrmann combines subjects such as White matter and NADPH oxidase with his study of Pathology. His studies in Dementia integrate themes in fields like Alzheimer's disease, Neuropathology and Neuroscience. His Molecular biology study combines topics from a wide range of disciplines, such as Tumor necrosis factor alpha, Recombinant DNA, Northern blot and Monocyte.
François Herrmann mostly deals with Internal medicine, Molecular biology, Immunology, Pathology and Endocrinology. His Internal medicine research incorporates elements of Gastroenterology, Surgery, Oncology and Cardiology. His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Gene expression, Cytokine, Monocyte and Monoclonal antibody.
In his work, Cancer research is strongly intertwined with Haematopoiesis, which is a subfield of Immunology. His study involves Alzheimer's disease, Neurofibrillary tangle and Dementia, a branch of Pathology. His study in Dementia focuses on Cognitive decline in particular.
The scientist’s investigation covers issues in Internal medicine, Particle physics, Nuclear physics, Hadron and Photon. François Herrmann has researched Internal medicine in several fields, including Endocrinology and Cardiology. His research in Nuclear physics intersects with topics in Deep inelastic scattering and Quantum chromodynamics.
His studies deal with areas such as Invariant mass and Isoscalar as well as Deep inelastic scattering. His Hadron study integrates concerns from other disciplines, such as Virtual particle, Branching fraction and Muon. François Herrmann works mostly in the field of Photon, limiting it down to topics relating to Large Hadron Collider and, in certain cases, Detector and Optics.
His scientific interests lie mostly in Nuclear physics, Particle physics, Quantum chromodynamics, Cognitive decline and Physical therapy. His Nuclear physics research integrates issues from Deep inelastic scattering and Photon. As a part of the same scientific study, he usually deals with the Cognitive decline, concentrating on Cognition and frequently concerns with Institutional repository and Audiology.
His Physical therapy research is multidisciplinary, relying on both Randomized controlled trial, Physical medicine and rehabilitation and Anxiety. His Cohort study results in a more complete grasp of Internal medicine. François Herrmann works on Internal medicine which deals in particular with Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Death toll exceeded 70,000 in Europe during the summer of 2003
Jean-Marie Robine;Siu Lan K. Cheung;Sophie Le Roy;Herman Van Oyen.
Comptes Rendus Biologies (2008)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.
Panteleimon Giannakopoulos;François Herrmann;T. Bussiere;T. Bussiere;Constantin Bouras;Constantin Bouras.
Neurology (2003)
Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors
Andreas Stephan Lübbe;Christian Bergemann;Hanno Riess;Folke Schriever.
Cancer Research (1996)
Serum albumin level on admission as a predictor of death, length of stay, and readmission.
FranÇois R. Herrmann;Charles Safran;Sue E. Levkoff;Kenneth L. Minaker.
JAMA Internal Medicine (1992)
Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death
Marion A. Brach;Sven deVos;Hans-Jürgen Gruss;Friedhelm Herrmann.
Blood (1992)
Physical Activity Reduces Systemic Blood Pressure and Improves Early Markers of Atherosclerosis in Pre-Pubertal Obese Children
Nathalie J. Farpour-Lambert;Yacine Aggoun;Laetitia M. Marchand;Xavier E. Martin.
Journal of the American College of Cardiology (2009)
Stops walking when talking: a predictor of falls in older adults?
Olivier Beauchet;C. Annweiler;V. Dubost;Gilles Allali.
European Journal of Neurology (2009)
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.
F Herrmann;S A Cannistra;H Levine;J D Griffin.
Journal of Experimental Medicine (1985)
Decreased blood pressure in NOX1-deficient mice.
Gaetan Gavazzi;Botond Banfi;Christine Deffert;Laurence Fiette.
FEBS Letters (2006)
Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure
Arnold Ganser;Albrecht Lindemann;Gernot Seipelt;Oliver G. Ottmann.
Blood (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Geneva
Albert Einstein College of Medicine
Georgia Institute of Technology
St Petersburg University
Columbia University
University of Perugia
Sao Paulo State University
Agricultural Research Service
Technical University of Munich
Osaka University
Lancaster University
Michigan State University
University of Colorado Denver
François Rabelais University
Columbia University
University of Padua
University of Groningen
Tel Aviv University